Timo Schinköthe

1.8k total citations
47 papers, 1.2k citations indexed

About

Timo Schinköthe is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Timo Schinköthe has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 12 papers in Genetics and 9 papers in Immunology. Recurrent topics in Timo Schinköthe's work include Chronic Lymphocytic Leukemia Research (6 papers), Advanced Breast Cancer Therapies (6 papers) and HER2/EGFR in Cancer Research (5 papers). Timo Schinköthe is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Advanced Breast Cancer Therapies (6 papers) and HER2/EGFR in Cancer Research (5 papers). Timo Schinköthe collaborates with scholars based in Germany, Argentina and Switzerland. Timo Schinköthe's co-authors include Annette Schmidt, Wilhelm Bloch, Peter Staib, Klara Brixius, Franz‐Josef Klinz, Andreas Engert, Robert H. G. Schwinger, Uwe Mehlhorn, Stefan Barth and Dennis Ladage and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Timo Schinköthe

45 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Timo Schinköthe Germany	17	592	287	260	242	233	47	1.2k
Elisa Gotti Italy	9	338 0.6×	366 1.3×	350 1.3×	142 0.6×	155 0.7×	13	908
Daniele Reverberi Italy	18	664 1.1×	869 3.0×	314 1.2×	140 0.6×	198 0.8×	46	1.6k
Joëlle Dulong France	14	631 1.1×	314 1.1×	501 1.9×	204 0.8×	365 1.6×	22	1.4k
Amit Nathwani United Kingdom	24	429 0.7×	601 2.1×	311 1.2×	204 0.8×	302 1.3×	67	1.5k
Soufiane Ghannam France	8	844 1.4×	355 1.2×	633 2.4×	120 0.5×	236 1.0×	11	1.7k
Shala Yuan Canada	11	696 1.2×	266 0.9×	256 1.0×	66 0.3×	184 0.8×	17	975
Peilong Lai China	15	452 0.8×	716 2.5×	265 1.0×	56 0.2×	286 1.2×	52	1.4k
Soraya Carrancio Spain	15	380 0.6×	298 1.0×	160 0.6×	200 0.8×	143 0.6×	33	1.0k
Basile Stamatopoulos Belgium	23	764 1.3×	779 2.7×	380 1.5×	229 0.9×	284 1.2×	50	1.6k
Sarah M. Churchman United Kingdom	21	511 0.9×	479 1.7×	389 1.5×	66 0.3×	138 0.6×	36	1.6k

Countries citing papers authored by Timo Schinköthe

Since Specialization

Citations

This map shows the geographic impact of Timo Schinköthe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timo Schinköthe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timo Schinköthe more than expected).

Fields of papers citing papers by Timo Schinköthe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timo Schinköthe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timo Schinköthe. The network helps show where Timo Schinköthe may publish in the future.

Co-authorship network of co-authors of Timo Schinköthe

This figure shows the co-authorship network connecting the top 25 collaborators of Timo Schinköthe. A scholar is included among the top collaborators of Timo Schinköthe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timo Schinköthe. Timo Schinköthe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Paradies, Kerstin, Timo Schinköthe, Renate Haidinger, et al.. (2024). Evaluation of therapy support through a standardized nursing consultation for patients undergoing oral tumor therapy in gynecological oncology within the prospective CAMPA initiative. European Journal of Oncology Nursing. 74. 102770–102770.

Schinköthe, Timo, et al.. (2024). The MedXFit-study – CrossFit as a workplace health intervention: a one-year, prospective, controlled, longitudinal, intervention study. Frontiers in Public Health. 12. 1304721–1304721. 1 indexed citations

Harbeck, Nadia, Ronald Kates, Timo Schinköthe, et al.. (2023). Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy. Cancer Treatment Reviews. 121. 102631–102631. 6 indexed citations

Schinköthe, Timo, et al.. (2023). Abstract P6-03-08: Trained Artificial Intelligence (AI) for Predicting Treatment Termination Based on Patient Observations in Advanced Breast Cancer. Cancer Research. 83(5_Supplement). P6–3.

Graf, Lisa, et al.. (2023). Diagnostic Accuracy of Single-Lead Electrocardiograms Using the Kardia Mobile App and the Apple Watch 4: Validation Study. JMIR Cardio. 7. e50701–e50701. 8 indexed citations

Harbeck, Nadia, Ronald Kates, Timo Schinköthe, et al.. (2023). 195P Impact of an interactive eHealth system for patient reported outcomes on safety in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy. ESMO Open. 8(1). 101384–101384. 1 indexed citations

Bartsch, Rupert, Nadia Harbeck, Matthias Zaiß, et al.. (2023). Abstract P2-01-01: Interim analysis (n=200) from ELEANOR: a multi-national, prospective, non-interventional study among patients with HER2+ and HR+ early breast cancer treated with extended adjuvant neratinib in the clinical routine. Cancer Research. 83(5_Supplement). P2–1. 1 indexed citations

Erickson, Nicole, Arndt Stahler, Maximilian Muenchhoff, et al.. (2022). Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV. Medical Oncology. 39(6). 104–104. 1 indexed citations

Schinköthe, Timo. (2019). Individualized eHealth Support for Oncological Therapy Management. Breast Care. 14(3). 130–134. 10 indexed citations

10.

Schinköthe, Timo, Wilhelm Bloch, & Annette Schmidt. (2008). In Vitro Secreting Profile of Human Mesenchymal Stem Cells. Stem Cells and Development. 17(1). 199–206. 161 indexed citations

11.

Schinköthe, Timo, Jeremy Franklin, Martin R. Weihrauch, et al.. (2008). Elevated pretreatment interleukin-10 serum level is an International Prognostic Score (IPS)-independent risk factor for early treatment failure in advanced stage Hodgkin lymphoma. Leukemia & lymphoma. 49(11). 2091–2098. 25 indexed citations

12.

Schmidt, Annette, et al.. (2007). Short intensive exercise increases the migratory activity of mesenchymal stem cells. British Journal of Sports Medicine. 43(3). 195–198. 24 indexed citations

13.

Schmidt, Annette, Dennis Ladage, Caroline Steingen, et al.. (2006). Mesenchymal stem cells transmigrate over the endothelial barrier. European Journal of Cell Biology. 85(11). 1179–1188. 93 indexed citations

14.

Koch, Andrea, Graham Sturton, Peter Staib, et al.. (2006). Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking. European Respiratory Journal. 29(1). 42–50. 29 indexed citations

15.

Staib, Peter, et al.. (2005). Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts. BMC Cancer. 5(1). 60–60. 4 indexed citations

16.

Staib, Peter, et al.. (2005). Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index C_i. British Journal of Haematology. 128(6). 783–791. 19 indexed citations

17.

Klinz, Franz‐Josef, Annette Schmidt, Timo Schinköthe, et al.. (2005). Phospho-eNOS Ser-114 in human mesenchymal stem cells: Constitutive phosphorylation, nuclear localization and upregulation during mitosis. European Journal of Cell Biology. 84(10). 809–818. 21 indexed citations

18.

Staib, Peter, et al.. (2005). Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors. Clinical Chemistry and Laboratory Medicine (CCLM). 44(1). 28–31. 18 indexed citations

19.

Engert, Andreas, Timo Schinköthe, F. Oberhäuser, et al.. (2000). A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia. Leukemia. 14(4). 754–766. 37 indexed citations

20.

Staib, Peter, B. Lathan, Timo Schinköthe, et al.. (1999). Prognosis in Adult AML is Precisely Predicted by the Disc-Assay Using the Chemosensitivity-Index CI. Advances in experimental medicine and biology. 457. 437–444. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact